Skip to main content
Ravindran M

Ravindran M

Study Director | Department In-Charge | Preclinical Toxicology | GLP

Talent
PuneMember since October 10, 2026
Preclinical ToxicologyGLPSOP implementationtoxicological risk assessmentpathologyclinical pathologytoxicokinetic dataacute toxicityrepeated-dose toxicityteratologyreproductive toxicitymedical devices studiesHPLC/LC-MS bioanalyticalWaters - MassLynx softwareStatistical Analysis of Toxicology DataFELASA training (Mice, Rat and Fish)Patent DraftingResearch Methodology in Natural SciencePreclinical and Reproductive Toxicity Endpoint AssessmentHET-CAM Assay (Hen’s Egg Test – Chorioallantoic Membrane)Artificial Intelligence in Drug Discovery, QSAR and Machine LearningComputational Drug Design
·

Hire this person

Send a job offer directly to this candidate

Preclinical ToxicologyGLPSOP implementationtoxicological risk assessmentpathology

About

Experienced Study Director and Toxicology Department In-Charge with 8+ years of expertise in GLP-compliant in-vivo preclinical studies across pharmaceuticals, medical devices, agrochemicals and vaccines. Proven track record in designing, executing and reporting regulatory toxicology studies in accordance with OECD GLP, ISO, EPA and FDA guidelines. Strong leadership in SOP implementation, audit readiness and cross-functional coordination.

Adept at handling end-to-end study lifecycle including protocol development, documentation and regulatory submissions.

Experience

Study Director at Vanta Bioscience Ltd. (2019-04 – Present)

  • Conducted and supervised GLP-compliant studies aligned with CCSEA, OECD GLP, NABL and AAALAC expectations.
  • Conducted GLP and NABL-compliant studies within the approved GLP Scope Certification and NABL accreditation scope, ensuring adherence to OECD GLP and ISO/IEC 17025 standards.
  • Managed study-related budgeting, cost estimation and pricing of toxicology studies, ensuring optimal resource utilization and alignment with sponsor requirements.
  • Act as primary point of contact for business development manager, sponsors, auditors and regulatory inspectors.
  • Provide technical leadership in toxicological risk assessment, integrating pathology, clinical pathology and toxicokinetic data.
  • Mentor, train and guide junior scientists and newly appointed Study Directors in study design, regulatory requirements, data interpretation and report preparation.
  • Oversee SOP implementation, quality assurance activities, support internal and external audits.

Study Scientist at Micro Therapeutic Research labs Pvt. Ltd. (2017-11 – 2019-04)

  • Acted as Study Director for GLP-compliant preclinical studies, ensuring full adherence to study protocols, SOPs and regulatory guidelines.
  • Prepared and reviewed SOPs, study plans, logbooks and final reports.
  • Performed acute toxicity, repeated-dose toxicity, teratology, reproductive toxicity and medical devices studies as per OECD, ICH, ISO 10993 and US Pharmacopeia.
  • Executed non-clinical safety studies adhering to 21 CFR Part 58 (GLP) standards to ensure data integrity for FDA submissions
  • Oversaw dosing, clinical observations, necropsy, organ collection, histopathology and overall conduct of the study.
  • Managed procurement of chemicals, reagents and study materials to support ongoing project timelines.
  • Ensured calibration (internal and external) and maintenance of laboratory instruments.
  • Experienced in utilizing Waters - MassLynx software to ensure 21 CFR Part 11 compliance and data integrity during high-throughput HPLC/LC-MS bioanalytical.

Department In-Charge – Toxicology

  • Conducted and supervised GLP-compliant studies aligned with CCSEA, OECD GLP, NABL and AAALAC expectations.
  • Conducted GLP and NABL-compliant studies within the approved GLP Scope Certification and NABL accreditation scope, ensuring adherence to OECD GLP and ISO/IEC 17025 standards.
  • Managed study-related budgeting, cost estimation and pricing of toxicology studies, ensuring optimal resource utilization and alignment with sponsor requirements.
  • Act as primary point of contact for business development manager, sponsors, auditors and regulatory inspectors.
  • Provide technical leadership in toxicological risk assessment, integrating pathology, clinical pathology and toxicokinetic data.
  • Mentor, train and guide junior scientists and newly appointed Study Directors in study design, regulatory requirements, data interpretation and report preparation.
  • Oversee SOP implementation, quality assurance activities, support internal and external audits.

Study Director / Technical Manager - Toxicology

  • Acted as Study Director for GLP-compliant preclinical studies, ensuring full adherence to study protocols, SOPs and regulatory guidelines.
  • Prepared and reviewed SOPs, study plans, logbooks and final reports.
  • Performed acute toxicity, repeated-dose toxicity, teratology, reproductive toxicity and medical devices studies as per OECD, ICH, ISO 10993 and US Pharmacopeia.
  • Executed non-clinical safety studies adhering to 21 CFR Part 58 (GLP) standards to ensure data integrity for FDA submissions
  • Oversaw dosing, clinical observations, necropsy, organ collection, histopathology and overall conduct of the study.
  • Managed procurement of chemicals, reagents and study materials to support ongoing project timelines.
  • Ensured calibration (internal and external) and maintenance of laboratory instruments.
  • Experienced in utilizing Waters - MassLynx software to ensure 21 CFR Part 11 compliance and data integrity during high-throughput HPLC/LC-MS bioanalytical.

IAEC Member Secretary

  • Manage the legal documentation and communication between the institution and the CCSEA to ensure full compliance.
  • Coordinate and manage Institutional Animal Ethics Committee (IAEC) activities in compliance with CCSEA.
  • Review and process animal study protocols, ensuring ethical justification, scientific validity and adherence to animal welfare standards.
  • Organize IAEC meetings, prepare agendas and minutes and maintain statutory documentation and records.
  • Monitor approved studies for compliance, conduct facility inspections and ensure implementation of IAEC recommendations.
  • Serve as liaison between investigators, regulatory authorities and committee members to ensure transparent and compliant animal research practices.

Education

Ph.D. in Medical Biotechnology – Chettinad Academy

M.Tech. in Biotechnology – Jeppiaar University

B.Tech. in Industrial Biotechnology – Bharath University

Skills

Study DirectorDepartment In-ChargePreclinical ToxicologyGLP

Reviews

Related